InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-5.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Calamari Christopher J., Chief Executive Officer. Officer active across 1 company, notably Abbott Laboratories. In total, 7 disclosures have been published. History available since 1 July 2021. The latest transaction was filed on 28 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
2,827 shares@ US$99.7745.5% of flowCommon shares without par valueSEC:0001415889-23-003896:0
10,560 shares0Common shares without par valueSEC:0001415889-23-003047:0
569 shares@ US$108.650.0000% mcap18.5% of flowCommon shares without par valueSEC:0001415889-22-007180:0
2,368 shares@ US$122.410.0001% mcap81.5% of flowCommon shares without par valueSEC:0001415889-22-002187:0
12,812 shares0Common shares without par valueSEC:0001415889-22-001731:0
3,764 shares0Common shares without par valueSEC:0001415889-21-003509
3,764 shares0Common shares without par valueSEC:0001415889-21-003509:0
7 of 7 declarations
About Calamari Christopher J.
Christopher J. Calamari is the CEO at Abbott Laboratories. He is responsible for the strategic and operational direction of the company. His role includes managing resources and making key decisions to ensure growth and profitability. Through his leadership, he guides the company towards achieving its long-term objectives.
